VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients

被引:6
作者
Chen, Fangfang [1 ]
Yin, Shuai [2 ]
Luo, Bin [1 ]
Wu, Xiaoyan [1 ]
Yan, Honglin [1 ]
Yan, Dandan [1 ]
Chen, Chuang [3 ]
Guan, Feng [1 ]
Yuan, Jingping [1 ]
机构
[1] Wuhan Univ, Dept Pathol, Renmin Hosp, 99 Zhangzhidong Rd, Wuhan 430060, Hubei, Peoples R China
[2] Yangtze Univ, Jingzhou Cent Hosp, Dept Gastroenterol, Clin Med Coll 2, Jingzhou, Hubei, Peoples R China
[3] Wuhan Univ, Dept Breast & Thyroid Surg, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
关键词
Diseases;
D O I
10.1155/2021/7647139
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim. The main objective of this article was to evaluate the association of voltage-dependent anion channel 1 (VDAC1) with Cytochrome C (Cytc) expression, various clinicopathological features, and prognosis in breast cancer (BC) patients. Meanwhile, the correlation of Cytc expression with various clinical features and 5-year disease-free survival (5-DFS) of BC was also investigated. Methods. In vivo, expression of VDAC1 and Cytc was examined in 219 BC tissues and 100 benign breast lesions by immunohistochemical (IHC) analysis. In vitro, MTT and wound healing migration assay were performed to detect the effect of VDAC1 on BC cells. Results. Expression of VDAC1 is conversely associated with Cytc in BC (P=0.011), especially in triple-negative breast cancer (TNBC) (P=0.004). Knockdown of VDAC1 inhibited proliferation (P<0.001) and migration (P<0.05) of MCF-7 cells. High expression of VDAC1 and low expression of Cytc had a significant association with multiple clinicopathological parameters (P<0.05) and poor 5-DFS (P<0.001) in BC. Conclusion. VDAC1 was elevated in BC tissues and conversely associated with Cytc. Detection of VDAC1 may provide guidance for the poor prognosis of BC, especially TNBC.
引用
收藏
页数:13
相关论文
共 40 条
  • [1] Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo (vol 3, pg e159, 2014)
    Arif, Tasleem
    Vasilkovsky, Lilia
    Refaely, Yael
    Konson, Alexander
    Shoshan-Barmatz, Varda
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 8 : 493 - 493
  • [2] Mitochondria as multifaceted regulators of cell death
    Bock, Florian J.
    Tait, Stephen W. G.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (02) : 85 - 100
  • [3] Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target
    Camara, Amadou K. S.
    Zhou, Yifan
    Wen, Po-Chao
    Tajkhorshid, Emad
    Kwok, Wai-Meng
    [J]. FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [4] Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
    Costa, Ana
    Kieffer, Yann
    Scholer-Dahirel, Alix
    Pelon, Floriane
    Bourachot, Brigitte
    Cardon, Melissa
    Sirven, Philemon
    Magagna, Ilaria
    Fuhrmann, Laetitia
    Bernard, Charles
    Bonneau, Claire
    Kondratova, Maria
    Kuperstein, Inna
    Zinovyev, Andrei
    Givel, Anne-Marie
    Parrini, Maria-Carla
    Soumelis, Vassili
    Vincent-Salomon, Anne
    Mechta-Grigoriou, Fatima
    [J]. CANCER CELL, 2018, 33 (03) : 463 - +
  • [5] Breast cancer statistics, 2019
    DeSantis, Carol E.
    Ma, Jiemin
    Gaudet, Mia M.
    Newman, Lisa A.
    Miller, Kimberly D.
    Sauer, Ann Goding
    Jemal, Ahmedin
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (06) : 438 - 451
  • [6] Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma
    Feichtinger, Rene Guenther
    Neureiter, Daniel
    Kemmerling, Ralf
    Mayr, Johannes Adalbert
    Kiesslich, Tobias
    Kofler, Barbara
    [J]. CELLS, 2019, 8 (06)
  • [7] Figueroa C M, 2017, J Nanomed Nanotechnol, V8, DOI 10.4172/2157-7439.1000427
  • [8] Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systemic Analysis for the Global Burden of Disease Study (vol 5, pg 1749, 2019)
    Fitzmaurice, C.
    Abate, D.
    Abbasi, N.
    [J]. JAMA ONCOLOGY, 2021, 7 (03) : 466 - 466
  • [9] Hierridin B Isolated from a Marine Cyanobacterium Alters VDAC1, Mitochondrial Activity, and Cell Cycle Genes on HT-29 Colon Adenocarcinoma Cells
    Freitas, Sara
    Martins, Rosario
    Costa, Margarida
    Leao, Pedro N.
    Vitorino, Rui
    Vasconcelos, Vitor
    Urbatzka, Ralph
    [J]. MARINE DRUGS, 2016, 14 (09):
  • [10] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674